EDGAR Filing Documents for 0001193125-09-184781

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001193125-09-184781

Filing Date

2009-08-31

Accepted

2009-08-31 17:01:16

Documents

Period of Report

2009-09-28

Effectiveness Date

2009-08-31

Document Format Files

Seq	Description	Document	Type	Size
1	DEFINITIVE PROXY STATEMENT	ddef14a.htm	DEF 14A	4352800
2	GRAPHIC	g76587g09v50.jpg	GRAPHIC	6410
3	GRAPHIC	g76587g15i80.jpg	GRAPHIC	10718
4	GRAPHIC	g76587g88m32.jpg	GRAPHIC	6526
5	GRAPHIC	g76587g93j66.jpg	GRAPHIC	4590
	Complete submission text file	0001193125-09-184781.txt		4393926

Mailing Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949

Business Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390

RAPTOR PHARMACEUTICALS CORP. (Filer) CIK: 0001203944 (see all company filings)

IRS No.: 980379351 | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 000-50720 | Film No.: 091046593
SIC: 2834 Pharmaceutical Preparations